Bart R. Anderson

1.3k citations

13 papers · 997 indexed · 1 hit paper · h-index 9

Co-authors: Drew Weissman Katalin Karikó Hiromi Muramatsu Philip C. Bevilacqua Lauren Sansing Subba Rao Nallagatla Babal K. Jha Robert H. Silverman
Topics: RNA modifications and cancer (5 papers)Immunotherapy and Immune Responses (5 papers)RNA Interference and Gene Delivery (5 papers)
Cited by: Molecular Biology Immunology Genetics
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research PLoS ONE
Partner nations: United States Ukraine

In The Last Decade

Bart R. Anderson

13 papers receiving 964 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

2010 478 citations Bart R. Anderson, Hiromi Muramatsu et al. Nucleic Acids Research profile →

Peers

Countries citing papers authored by Bart R. Anderson

Since Specialization

Citations

This map shows the geographic impact of Bart R. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart R. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart R. Anderson more than expected).

Fields of papers citing papers by Bart R. Anderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart R. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart R. Anderson. The network helps show where Bart R. Anderson may publish in the future.

Co-authorship network of co-authors of Bart R. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Bart R. Anderson. A scholar is included among the top collaborators of Bart R. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart R. Anderson. Bart R. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	FMRP - G-quadruplex mRNA - miR-125a interactions: Implications for miR-125a mediated translation regulation of PSD-95 mRNA 2019 ·PLoS ONE ·(unknown),(unknown),(unknown),(unknown),Bart R. Anderson,Gary J. Bassell,Mihaela‐Rita Mihailescu	25
2	Targeting the IL-17 Receptor Using Liposomal Spherical Nucleic Acids as Topical Therapy for Psoriasis 2019 ·Journal of Investigative Dermatology ·Haoming Liu,Richard S. Kang,(unknown),Jeong Min Yu,(unknown),Weston L. Daniel,Bart R. Anderson,(unknown),Andrew Schook,R. P. Agarwal,David A. Giljohann,Amy S. Paller	49
3	Abstract 3217: Preclinical evaluation of the recombinant dendritic cell growth factor CDX-301 (Flt3L), and AST-008, a TLR9 agonist SNA 2019 ·Cancer Research ·Lawrence J. Thomas,Li-Zhen He,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Anna Wasiuk,(unknown),Henry C. Marsh,Bart R. Anderson,(unknown),Richard S. Kang,Ekambar R. Kandimalla,Tibor Keler	2
4	Abstract A136: AST-008, a novel TLR9 agonist SNA, induces abscopal antitumor effects in mouse tumor models 2019 ·Cancer Immunology Research ·Ekambar R. Kandimalla,(unknown),Bart R. Anderson,Richard S. Kang	6
5	Inhibition of the Schizophrenia-Associated MicroRNA miR-137 Disrupts Nrg1α Neurodevelopmental Signal Transduction 2017 ·Cell Reports ·(unknown),Bart R. Anderson,Niraj Shah,Stephanie Zimmer,Daniel Hawkins,Arielle N. Valdez‐Sinon,(unknown),Gary J. Bassell	46
6	Abstract 4706: Spherical nucleic acids targeting toll-like receptor 9 enhance antitumor activity in combination with anti-PD-1 antibody in mouse tumor models 2017 ·Cancer Research ·(unknown),Bart R. Anderson,(unknown),Ekambar R. Kandimalla	3
7	Identification of consensus binding sites clarifies FMRP binding determinants 2016 ·Nucleic Acids Research ·Bart R. Anderson,Pankaj Chopra,Joshua A. Suhl,Stephen T. Warren,Gary J. Bassell	43
8	A 3′ untranslated region variant in FMR1 eliminates neuronal activity-dependent translation of FMRP by disrupting binding of the RNA-binding protein HuR 2015 ·Proceedings of the National Academy of Sciences ·Joshua A. Suhl,Ravi Muddashetty,Bart R. Anderson,Marius F. Ifrim,Jeannie Visootsak,Gary J. Bassell,Stephen T. Warren	24
9	Analysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences 2014 ·Human Molecular Genetics ·Joshua A. Suhl,Pankaj Chopra,Bart R. Anderson,Gary J. Bassell,Stephen T. Warren	60
10	Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK 2012 ·Gene Therapy ·Bart R. Anderson,Katalin Karikó,Drew Weissman	14
11	Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L 2011 ·Nucleic Acids Research ·Bart R. Anderson,Hiromi Muramatsu,Babal K. Jha,Robert H. Silverman,Drew Weissman,Katalin Karikó	243
12	Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activationbreakdown → 2010 ·Nucleic Acids Research ·Bart R. Anderson,Hiromi Muramatsu,Subba Rao Nallagatla,Philip C. Bevilacqua,Lauren Sansing,Drew Weissman,Katalin Karikó	478
13	Induction of HIV‐specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine 2008 ·European Journal of Immunology ·(unknown),Bart R. Anderson,Drew Weissman	4

About Bart R. Anderson

Bart R. Anderson is a scholar working on Immunology, Virology and Genetics, having authored 13 papers that have together received 997 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Immunotherapy and Immune Responses (5 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Molecular Biology (837 citations), Immunology (233 citations) and Genetics (254 citations). Bart R. Anderson has collaborated with scholars based in United States and Ukraine. Frequent co-authors include Drew Weissman, Katalin Karikó, Hiromi Muramatsu, Philip C. Bevilacqua, Lauren Sansing, Subba Rao Nallagatla, Babal K. Jha, Robert H. Silverman, Gary J. Bassell and Joshua A. Suhl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact